Molecular characterization of a purified 5-HT4 receptor -: A structural basis for drug efficacy

被引:121
作者
Banères, JL
Mesnier, D
Martin, A
Joubert, L
Dumuis, A
Bockaert, J
机构
[1] Fac Pharm Montpellier, CNRS, UMR 5074, F-34093 Montpellier, France
[2] Univ Montpellier 2, Univ Montpellier 1, INSERM U661, UMR 5203,CNRS, F-34094 Montpellier, France
[3] Inst Genom Fonct, Dept Neurobiol, F-34094 Montpellier, France
关键词
D O I
10.1074/jbc.M412009200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin 5-HT4(a) receptor, a G-protein-coupled receptor (GPCR), was produced as a functional isolated protein using Escherichia coli as an expression system. The isolated receptor was characterized at the molecular level by circular dichroism (CD) and steady-state fluorescence. A specific change in the near-UV CD band associated with the GPCR disulfide bond connecting the third transmembrane domain to the second extracellular loop (e2) was observed upon agonist binding to the purified receptor. This is a direct experimental evidence for a change in the conformation of the e2 loop upon receptor activation. Different variations were obtained depending whether the ligand was an agonist ( partial or full) or an inverse agonist. In contrast, antagonist binding did not induce any variation. These observations provide a first direct evidence for the fact that free ( or antagonist-occupied), active (partial- or full agonist-occupied) and silent (inverse agonist-occupied) states of the receptor involve different arrangements of the e2 loop. Finally, ligand-induced changes in the fluorescence emission profile of the purified receptor confirmed that the partial agonist stabilized a single, well-defined, conformational state and not a mixture of different states. This result is of particular interest in a pharmacological perspective since it directly demonstrates that the efficacy of a drug is likely due to the stabilization of a ligand-specific state rather than selection of a mixture of different conformational states of the receptor.
引用
收藏
页码:20253 / 20260
页数:8
相关论文
共 38 条
[21]  
LUMMIS SCR, 1992, MOL PHARMACOL, V41, P18
[22]   VARIABLE SELECTION METHOD IMPROVES THE PREDICTION OF PROTEIN SECONDARY STRUCTURE FROM CIRCULAR-DICHROISM SPECTRA [J].
MANAVALAN, P ;
JOHNSON, WC .
ANALYTICAL BIOCHEMISTRY, 1987, 167 (01) :76-85
[23]   Three-dimensional model for Meta-II rhodopsin, an activated G-protein-coupled receptor [J].
Nikiforovich, GV ;
Marshall, GR .
BIOCHEMISTRY, 2003, 42 (30) :9110-9120
[24]   Activation of rhodopsin: new insights from structural and biochemical studies [J].
Okada, T ;
Ernst, OP ;
Palczewski, K ;
Hofmann, KP .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (05) :318-324
[25]   Crystal structure of rhodopsin: A G protein-coupled receptor [J].
Palczewski, K ;
Kumasaka, T ;
Hori, T ;
Behnke, CA ;
Motoshima, H ;
Fox, BA ;
Le Trong, I ;
Teller, DC ;
Okada, T ;
Stenkamp, RE ;
Yamamoto, M ;
Miyano, M .
SCIENCE, 2000, 289 (5480) :739-745
[26]   Optimized bacterial expression of human apolipoprotein A-I [J].
Ryan, RO ;
Forte, TM ;
Oda, MN .
PROTEIN EXPRESSION AND PURIFICATION, 2003, 27 (01) :98-103
[27]  
SAMAMA P, 1993, J BIOL CHEM, V268, P4625
[28]  
Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218
[29]   The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice [J].
Shi, L ;
Javitch, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :440-445
[30]  
Sillen A, 2001, SPR S FLUOR, V1, P413